These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33338262)

  • 1. Differential mast cell phenotypes in benign versus cancer tissues and prostate cancer oncologic outcomes.
    Hempel Sullivan H; Maynard JP; Heaphy CM; Lu J; De Marzo AM; Lotan TL; Joshu CE; Sfanos KS
    J Pathol; 2021 Apr; 253(4):415-426. PubMed ID: 33338262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Extratumoral Mast Cell Counts Are Associated with a Higher Risk of Adverse Prostate Cancer Outcomes.
    Hempel Sullivan H; Heaphy CM; Kulac I; Cuka N; Lu J; Barber JR; De Marzo AM; Lotan TL; Joshu CE; Sfanos KS
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):668-675. PubMed ID: 31932412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors.
    Andersen LB; Nørgaard M; Rasmussen M; Fredsøe J; Borre M; Ulhøi BP; Sørensen KD
    J Pathol; 2021 Oct; 255(2):155-165. PubMed ID: 34255349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis.
    Fleischmann A; Schlomm T; Köllermann J; Sekulic N; Huland H; Mirlacher M; Sauter G; Simon R; Erbersdobler A
    Prostate; 2009 Jun; 69(9):976-81. PubMed ID: 19274666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune cell infiltrates and prognosis in localized prostate cancer
    Sfanos KS
    J Pathol; 2022 Feb; 256(2):135-138. PubMed ID: 34694014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor infiltrating B-cells are increased in prostate cancer tissue.
    Woo JR; Liss MA; Muldong MT; Palazzi K; Strasner A; Ammirante M; Varki N; Shabaik A; Howell S; Kane CJ; Karin M; Jamieson CA
    J Transl Med; 2014 Jan; 12():30. PubMed ID: 24475900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cell phenotype in benign and malignant tumors of the prostate.
    Globa T; Saptefrţi L; Ceauşu RA; Gaje P; Cimpean AM; Raica M
    Pol J Pathol; 2014 Jun; 65(2):147-53. PubMed ID: 25119176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast Cells in the Tumor Microenvironment.
    Aponte-López A; Muñoz-Cruz S
    Adv Exp Med Biol; 2020; 1273():159-173. PubMed ID: 33119881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Intratumoral Mast Cells Are Associated With a Higher Risk of Prostate Cancer Recurrence.
    Hempel HA; Cuka NS; Kulac I; Barber JR; Cornish TC; Platz EA; De Marzo AM; Sfanos KS
    Prostate; 2017 Mar; 77(4):412-424. PubMed ID: 27868214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer.
    Nonomura N; Takayama H; Nishimura K; Oka D; Nakai Y; Shiba M; Tsujimura A; Nakayama M; Aozasa K; Okuyama A
    Br J Cancer; 2007 Oct; 97(7):952-6. PubMed ID: 17848955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic Assessment of Tumors from a Race-matched Military Cohort Identifies Mast Cell Depletion as a Marker of Prostate Cancer Progression.
    Schafer CC; Jiang J; Elsamanoudi S; Nousome D; Young DY; Song Y; Sesterhenn IA; Chesnut GT; Tan SH
    Cancer Res Commun; 2023 Aug; 3(8):1423-1434. PubMed ID: 37534375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human C1q Tumor Necrosis Factor 8 (CTRP8) defines a novel tryptase+ mast cell subpopulation in the prostate cancer microenvironment.
    Krishnan SN; Thanasupawat T; Arreza L; Wong GW; Sfanos K; Trock B; Arock M; Shah GG; Glogowska A; Ghavami S; Hombach-Klonisch S; Klonisch T
    Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166681. PubMed ID: 36921737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue engineered human prostate microtissues reveal key role of mast cell-derived tryptase in potentiating cancer-associated fibroblast (CAF)-induced morphometric transition in vitro.
    Pereira BA; Lister NL; Hashimoto K; Teng L; Flandes-Iparraguirre M; Eder A; Sanchez-Herrero A; Niranjan B;
    Biomaterials; 2019 Mar; 197():72-85. PubMed ID: 30641266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer.
    Jachetti E; Cancila V; Rigoni A; Bongiovanni L; Cappetti B; Belmonte B; Enriquez C; Casalini P; Ostano P; Frossi B; Sangaletti S; Chiodoni C; Chiorino G; Pucillo CE; Tripodo C; Colombo MP
    Cancer Immunol Res; 2018 May; 6(5):552-565. PubMed ID: 29523597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers.
    Pittoni P; Tripodo C; Piconese S; Mauri G; Parenza M; Rigoni A; Sangaletti S; Colombo MP
    Cancer Res; 2011 Sep; 71(18):5987-97. PubMed ID: 21896641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment.
    Xu W; Qian J; Zeng F; Li S; Guo W; Chen L; Li G; Zhang Z; Wang QJ; Deng F
    J Exp Clin Cancer Res; 2019 Mar; 38(1):114. PubMed ID: 30841931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pro-tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment.
    Ellem SJ; Taylor RA; Furic L; Larsson O; Frydenberg M; Pook D; Pedersen J; Cawsey B; Trotta A; Need E; Buchanan G; Risbridger GP
    J Pathol; 2014 Sep; 234(1):86-98. PubMed ID: 25042571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population.
    Li L; Dang Q; Xie H; Yang Z; He D; Liang L; Song W; Yeh S; Chang C
    Oncotarget; 2015 Jun; 6(16):14179-90. PubMed ID: 25895025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival.
    Sorrentino C; Yin Z; Ciummo S; Lanuti P; Lu LF; Marchisio M; Bellone M; Di Carlo E
    J Immunother Cancer; 2019 Jul; 7(1):201. PubMed ID: 31366386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.